Exogenous MDK and MDK from cancer-associated fibroblasts was able to decrease cisplatin-induced cell death in oral squamous cell carcinoma, ovarian cancer, and lung cancer by upregulating the expression of BCL2 [17]. The gene discussed is MDK; the disease is ovarian carcinoma.